Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review

10.1371/journal.pone.0077901

Saved in:

Bibliographic Details
Main Authors:	Rui Y.-Y., Zhang D., Zhou Z.-G., Wang C., Yang L., Yu Y.-Y., Chen H.-N.
Other Authors:	ELECTRICAL AND COMPUTER ENGINEERING
Format:	Article
Published:	2019
Subjects:	antineoplastic agent fluorouracil folinic acid irinotecan levamisole oxaliplatin adjuvant therapy article cancer prognosis cancer staging case control study cohort analysis colorectal cancer denaturing gradient gel electrophoresis disease free survival gene mutation human long term survival meta analysis oncogene K ras overall survival polymerase chain reaction pyrosequencing quality control restriction fragment length polymorphism sample size single strand conformation polymorphism systematic review Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Colorectal Neoplasms Humans Mutation Prognosis Proto-Oncogene Proteins ras Proteins Survival Rate Tumor Markers, Biological
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161460
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!